When predicting pathologic response to neoadjuvant chemotherapy, changes in breast tumor size measured at MRI are superior indicators to clinical assessment, with the greatest advantage seen using volumetric measurements of tumor response early in treatment, according to a study published in the June issue of Radiology.

Mobile technology is hot right now. So hot that President Barack Obama has declared a presidential mandate directing federal agencies to implement such technology within the next 12 months.

Pennsylvanias 2.1 million citizens covered by state-administered Medicaid, including those in the most rural and remote areas, are about to begin enjoying access to the best medical specialists in the state. Thats because, on May 23, the state broadened its coverage to reimburse far more telemedicine consultations than it previously paid for.

As Americas hospitals and healthcare systems face mounting threats to their long-term fiscal health, healthcare technology managers find themselves eyeing an unprecedented opportunity to help their respective C-suite leaders minimize the hurt and hasten the healing.

Daily low-dose administrations of the chemotherapy drug carboplatin combined with radiotherapy significantly prolonged the survival of elderly lung cancer patients compared with radiotherapy alone, offering hope that the standard treatment for inoperable non-small-cell lung cancer (NSCLC) can be extended to patients ages 65 and older, according to a study published online May 22 in The Lancet Oncology.

Health and Human Services (HHS) Secretary Kathleen Sebelius and Mexico Secretary of Health Salomn Chertorivski announced a series of new steps to strengthen health security cooperation between the two countries.

The use of stereotactic body radiation therapy (SBRT) rather than intensity-modulated radiation therapy for low- to intermediate-risk prostate cancer could produce a win-win combination and curb ballooning prostate cancer treatment costs while also trimming individual indirect costs to patients, according to a study published online in the May issue of the American Journal of Managed Care.

The U.S. Preventive Services Task Force (USPSTF) issued a Grade D rating for prostate-specific antigen (PSA)-based screening for prostate cancer on May 21, a move that could result in fewer men being diagnosed with early, curable prostate cancer and more men presenting with advanced stages of disease.